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Objective: Dysfunction of the coronary microcirculation is considered as one of the factors
responsible for symptoms and abnormal stress tests in patients with angina and normal
coronaries (syndrome X). We sought to evaluate the usefulness of coronary sinus filling
time (CSFT) to assess coronary microcirculation in this group of patients.
Methods: We compared the CSFT of patients having definite angina or atypical angina with
positive treadmill electrocardiography test (angina group), with that of patients undergoing
coronary angiogram (CAG) prior to balloon mitral valvuloplasty (control group). During
CAG, coronary sinus was visualized in appropriate views and CSFT in seconds was derived
from frame count. Thrombolysis In Myocardial Infarction (TIMI) flow grade, corrected TIMI
(cTIMI) frame count, TIMI Myocardial Perfusion grade (TMP) were assessed.
Results: There were 41 patients in angina group and 16 in control group. Among the angina
group 68.8% were females as against 81.8% in the control group. 87.8% (n ¼ 36) had typical
angina. Mean CSFT was 4.25  0.72 s and 3.46  0.99 s in the angina group and control
group respectively (p ¼ 0.001). No significant differences were found between the groups
with respect to TMP (p ¼ 0.68) & cTIMI frame count (p ¼ 0.22).
Conclusion: CSFT is a simple method to assess the transit time through coronary micro-
circulation. CSFT was significantly delayed in patients with angina and normal coronaries.
TMP and cTIMI frame count were not significantly different between groups.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction angina, a positive exercise stress test, normal epicardial cor-Twenty percent of all diagnostic angiograms in patients
referred for evaluation of chest pain have normal epicardial
coronary arteries.1 First described by Kemp in 1973, syndrome
X comprises of a heterogenous group presenting with typical, þ91 9846697553.
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2013, Cardiological Socieonaries and no clinical or angiographic evidence of epicardial
coronary artery spasm.2 Dysfunction of the coronary micro-
circulationmay be one of the factors responsible for persistent
anginal symptoms and abnormal stress test.3,4 Prognosis of
these patients is not as benign as reported by preliminarym (M.N. Krishnan).
ty of India. All rights reserved.
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myocardial infarction and cardiac death, especially in patients
with positive stress test.5,6 Women Ischemic Symptom Eval-
uation (WISE) trial showed that persistence of symptoms is
associatedwithmore than two-fold increase in cardiovascular
events and concluded that such patients should undergo
formal studies of vascular function and aggressive risk factor
modification.7 Noninvasive as well as invasive modes for
assessing microcirculation have yielded inconsistent results
and there is yet no simple method available at present to
assess coronary microcirculation.8e10 In this study, we have
attempted to evaluate the usefulness of coronary sinus filling
time (CSFT) for assessment of microcirculatory transit time in
the coronary circulation.2. Patients and methods
Adult patients presenting to the cardiology department of a
major teaching hospital with angina-like chest pain from June
2011 to January 2012 were screened for this study.
The assessment of chest pain was done by two cardiolo-
gists of the department separately and doubtful cases were
reviewed by a third cardiologist. Patients with chest pain were
grouped into: 1) definite angina with/without positive TMT 2)
probable angina with positive TMT and 3) non-cardiac chest
pain. Definite (typical) angina was defined as substernal chest
discomfort 1) of characteristic quality and duration 2) pro-
voked by exertion or emotional stress 3) relieved by rest orFig. 1 e Flow diagram showing the ensublingual nitrites. Probable angina was defined as those that
met any two of the above characteristics; non-cardiac chest
pain as those meeting one or none of the characteristics.11
Baseline evaluation, electrocardiogram (ECG) and echo-
cardiography were done in all subjects. Definite and probable
angina group underwent TMT. Patients were grouped as
having either positive, negative or inconclusive test result
based on standard criteria.12 Patients with definite angina
regardless of the result of TMT and patients with probable
angina and a positive stress test were subjected to CAG.
Among patients undergoing CAG, those with normal coro-
naries formed the angina group. The control group consisted
of patients with mitral stenosis in sinus rhythm, normal cor-
onary angiogram and normal left ventricular structure and
function undergoing percutaneous balloon mitral valvulo-
plasty (BMV). The right atrial pressures and left ventricular
end diastolic pressures were measured in all cases. Exclusion
criteria were: 1) abnormal coronaries on angiography (any
vascular irregularity/ectasia/stenoses), 2) patients with cur-
rent or prior cardiovascular events by history, ECG or echo-
cardiography, 3) presence of cardiac diseases other than
isolated mitral stenosis. Fig. 1 outlines the selection of pa-
tients for the study.
Coronary angiogram was done with Philips Allura Xper
FD20 (Philips Electronics, Eindhoven, The Netherlands) at a
rate of 15 frames/s. Left coronary artery injection was taken
with 7 mL contrast at 2 mL/s rate. A normal coronary artery
was defined as epicardial coronary artery at angiography
without any wall irregularities, ectasia or stenosis. TIMIrollment of patients for the study.
Table 1 e Baseline characteristics of patients and
controls.
Parameter Angina
group n (%)
Control
group n (%)
p value
Sex
M 13 (31.7) 3 (18.8)
F 28 (68.3) 13 (81.2) 0.108
Age e Mean (SD) 50.4 (7.6) 47.4 (9.6) 0.064
Diabetes mellitus 16 (39) 2 (12.5) 0.053
Hypertension 22 (53.7) 1 (6.2) 0.001
Dyslipidemia 18 (43.9) 1 (6.2) 0.007
Smoking 11 (26.8) 2 (12.5) 0.2
Family history of CAD 6 (14.3) 0 0.11
Heart rate e Mean (SD) 74 (12) 77 (14) 0.08
RA pressure e Mean (SD) 3.4 (2.5) 5.3 (3.48) 0.06
LV EDP 7 (3.6) 6 (2.4) 0.18
Drugs
1. Beta blockers 11 16 0.12
2. CCB 8 2 0.04
3. Statins 18 0 0.02
4. Nitrates 32 0 0.003
5. ACEI/ARB 18 4 0.03
6. Aspirin 32 4 0.004
RA ¼ Right atrium; LVEDP ¼ Left ventricular end diastolic pressure;
CCB ¼ Calcium channel blocker; ACEI ¼ Angiotensin converting
enzyme inhibitor; ARB ¼ Angiotensin receptor blocker.
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CSFT was defined as the time taken in seconds for the
contrast agent in the epicardial coronary artery to traverse
the coronary microvasculature and reach the coronary sinus
origin. CSFT was estimated as the difference between the
frame count of maximum left anterior descending artery
(LAD) system opacification at first diagonal (D1)/first septal
(S1) to that of the starting point of opacification of coronary
sinus origin.
Frame count at the maximum opacification of LAD at D1 or
S1, whichever was earlier (first frame count), was noted. A
column of fully concentrated dye must extend across the
entire width of LAD at D1/S1 and move forwards. The frame
count in which dye is first seen at the origin of coronary sinus
is counted as the last frame and the frame count was noted
(last frame count). Coronary sinus origin is defined as the
point where great cardiac vein joins the posterolateral vein
(that is marked by the joining of oblique vein of Marshall to
coronary sinus in whom it is seen). Coronary sinus was eval-
uated in at least two views, left anterior oblique (LAO) with
appropriate cranial angulation and right anterior oblique
(RAO) with caudal tilt. In these views, the tract and effluent
were well visualized draining into the right atrium after
sixeeight cycles on an average. The CSFT is calculated as:
CSFT in seconds ¼ ðlast frame count first frame count=15Þ
TIMI Frame Count is defined as the number of angiographic
frames elapsed from the first frame inwhich the contrast fully
enters the artery to that in which it reaches the distal stan-
dardized landmark of the vessel of interest.
For LAD, TIMI frame count [ Frame count at distal
bifurcation e frame count at D1.
The frame rates are corrected for the longer length of the
LAD by dividing it by 1.7.13 TMP is a simple descriptive score of
myocardial opacification with contrast, distinct from the
epicardial vessel, and provides a score of between 0 (no
myocardial blush) and 3 (normal blush and clearance of dye
from myocardium).14,15 cTIMI frame count, TMP and CSFT in
both the groups was compared and correlation analyzed.
Analysis was done using two tailed t-test for equality of
means. The demographic data was analyzed using Chi square
test and Pearson correlation for correlation between CSFT
frame count and cTIMI frame count.Fig. 2 e Coronary sinus filling time in angina group and
control group.3. Results
There were 41 cases in the angina group and 16 in the control
group. Baseline data of both groups are given in (Table 1).
Angina group and control group were compared with
respect to following parameters e cTIMI frame, TMP Grade
and CSFT. Mean CSFT frame count in angina group and in
control groupwere 63.76 10.7 and 52.06 5.0 andmeanCSFT
were 4.2476 0.72 s and 3.4581 0.99 s, respectively (p¼ 0.001)
(Fig. 2). We could demonstrate a positive correlation between
CSFT and cTIMI frame count in the angina group (correlation
coefficient ¼ 0.7) (Fig. 3).
No significant differences were found between the two
groups with regard to cTIMI (23.97  6.2 in angina group and21.84  5.0 in the control group p ¼ 0.224) or TMP (2.9  0.3 in
angina group and 2.94  0.25 in control group p ¼ 0.68).4. Discussion
Our study demonstrated a delay in transit through microcir-
culation in patients with angina and normal coronaries. In a
similar study, Sankareddi et al16 have proposed that the time
delay between LAD opacification and filling of coronary sinus
would indicate the microcirculatory time. They went on to
define CSFT as the difference in frame counts between
maximum LAD opacification to the maximal opacification of
the coronary sinus. They also calculated coronary sinus
emptying time and coronary sinus emptying velocity as pa-
rameters to assess microcirculatory transit. In our study, we
Fig. 3 e Correlation of cTIMI frame count and CSFT.
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velocity depend on the drainage characteristics of coronary
sinus rather than that of the coronary microcirculation. We
modified the definition of CSFT as the difference in frame
counts betweenmaximum LAD opacification to the beginning
of filling of coronary sinus origin. The coronary sinus is a
venous conduit, which drains between 80% and 85% of un-
saturated blood of the left ventricle.17 Studies have shown
that there is dynamic variation of the coronary sinus lumen
during normal cardiac cycle and has been categorized into
passive, normal response and hyperactive.18 An exaggerated
response to this mechanism could potentially modify cyclic
coronary circulation and perfusion, causing slow flow phe-
nomena.19 Modulation of coronary sinus outflow pressure in
normal canine hearts affects intramyocardial tissue pressure
and has been shown to reduce blood flow in the subepicardial
tissue layer independently of coronary artery pressure.20
Since the maximal opacification of the coronary sinus would
depend on multiple factors other than the condition of the
microcirculation, we decided to assess the filling at the origin
of coronary sinus. Our study agrees with the previous study
that CSFT is delayed in angina with normal coronaries. Our
study had a larger study population (n ¼ 41) compared to the
previous study (n¼ 10).We also compared other parameters of
perfusion, cTIMI frame count and TMP. These two parameters
were not significantly different between angina group and
control group as in other studies.14,21,22 In our study there was
a positive correlation between cTIMI frame count & CSFT in
the case group (r ¼ 0.730). There was a trend toward delayed
CSFT in those patients with an increased cTIMI frame count.
Mahfouz et al could demonstrate a marked delay in cTIMI
frame count in a group of syndrome X patients, even though
other studies have yielded mixed results.23 A few studies
could demonstrate abnormal TMP as a surrogate marker for
dysfunctional coronary microvasculature in syndrome X.24
We could not demonstrate any correlation between TMP and
CSFT in this study.We have not been able to find any study examining the
relation between CSFT and long-term outcomes; nor could we
find any study on the effect of coronary dilators like adenosine
or dipyridamole on CSFT. It would be worthwhile to study the
differential power of CSFT on long-term outcomes in patients
with angina and normal coronaries.
Therewere several limitations in our study, as this was one
of the pilot studies of CSFT. One of the limitations of this study
was the small number of control population. We could not
recruit absolutely normal subjects as control population
because of ethical issues. We took mitral stenosis patients
undergoing CAG prior to BMV as controls. In case of control
population, we had to exclude patients with mean pulmonary
artery pressure 25 mmHg, as elevated right atrial pressures
prolonged coronary sinus filing time. Another limitation was
that coronary spasm was not excluded. We did not stan-
dardize the injection speed and force as we used hand injec-
tion; this could have affected the results. However, Gibson
et al have shown that the difference in hardware, injection
methods and phase of cardiac cycle did not produce much
variability in corrected frame count calculation.13 Sincewe did
not come across any study that used automated injectors for
standardization our study used manual injections at pre-
specified rate and volume. Our study group and controls have
a preponderance of female subjects; thus it is not clear
whether the conclusions can be extended to male patients.
CSFTmay be proposed as amethod to risk-stratify patients
with angina and normal coronaries. Moreover, CSFT may be
used as a simple and quantitative test in percutaneous coro-
nary intervention setting to assess myocardial reperfusion.
Further studies are required to evaluate this proposition.5. Conclusion
CSFT is a simple method to assess the transit time through
coronary microcirculation. CSFT was significantly delayed in
patients with angina and normal coronaries. TMP and cTIMI
frame count did not differ significantly between the groups
studied.Conflicts of interest
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